ATE248373T1 - Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonisten - Google Patents

Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonisten

Info

Publication number
ATE248373T1
ATE248373T1 AT96918089T AT96918089T ATE248373T1 AT E248373 T1 ATE248373 T1 AT E248373T1 AT 96918089 T AT96918089 T AT 96918089T AT 96918089 T AT96918089 T AT 96918089T AT E248373 T1 ATE248373 T1 AT E248373T1
Authority
AT
Austria
Prior art keywords
gpcrs
antagonists
identify
indicator cells
protein
Prior art date
Application number
AT96918089T
Other languages
English (en)
Inventor
David I Israel
Christopher J Molineaux
Original Assignee
Praecis Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23905512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE248373(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Praecis Pharm Inc filed Critical Praecis Pharm Inc
Application granted granted Critical
Publication of ATE248373T1 publication Critical patent/ATE248373T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Physiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96918089T 1995-06-07 1996-06-05 Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonisten ATE248373T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47980395A 1995-06-07 1995-06-07
PCT/US1996/008895 WO1996041169A1 (en) 1995-06-07 1996-06-05 Functional bioassay for g-protein coupled receptor agonists and antagonists

Publications (1)

Publication Number Publication Date
ATE248373T1 true ATE248373T1 (de) 2003-09-15

Family

ID=23905512

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918089T ATE248373T1 (de) 1995-06-07 1996-06-05 Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonisten

Country Status (8)

Country Link
EP (1) EP0830600B1 (de)
JP (1) JPH11507518A (de)
AT (1) ATE248373T1 (de)
AU (1) AU730875C (de)
CA (1) CA2220715C (de)
DE (1) DE69629684T2 (de)
DK (1) DK0830600T3 (de)
WO (1) WO1996041169A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2186979A1 (en) * 1996-10-02 1998-04-02 Michael Dennis Methods of testing antagonists for their abilities to affect the activity of g protein-coulpled receptors
CA2192754A1 (en) 1996-12-12 1998-06-12 Jacques Drouin Nur-re a response element which binds dimers of nur nuclear receptors and method of use therefor
US6403305B1 (en) * 1997-02-06 2002-06-11 Cornell Research Foundation, Inc. Methods of identifying peptide agonists or negative antagonists of a G protein coupled receptor
EP0874047A3 (de) 1997-04-22 2000-04-19 Smithkline Beecham Corporation CDNS Klon HMTMF81 der für einen neuen menschlichen 7-Transmembranrezeptor kodiert
EP0878542A3 (de) * 1997-04-22 2000-04-19 Smithkline Beecham Corporation CDNS Klon HMTMF81 der für einen neuen menschlichen 7-Transmembranrezeptor kodiert
US20020146740A1 (en) * 1997-10-09 2002-10-10 William D. Huse Method for identifying optimal binding ligands to a receptor
JP2002521681A (ja) * 1998-07-31 2002-07-16 アリーナ・フアーマシユーチカルズ・インコーポレーテツド 内因性の構成的に活性化されるgタンパク質−共役オーファン受容体
WO2001050127A2 (en) * 1999-12-30 2001-07-12 7Tm Pharma Screening using biological target molecules with metal-ion binding sites
US7732133B2 (en) 2000-07-17 2010-06-08 Chugai Seiyaku Kabushiki Kaisha Screening methods for biologically active ligands
US6902902B2 (en) * 2001-11-27 2005-06-07 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders
EP2490021A1 (de) * 2011-02-18 2012-08-22 Biotempt B.V. Modulatoren von PRR- und GPCR-Signalisierung
KR101452864B1 (ko) 2011-11-17 2014-11-04 서울대학교산학협력단 Gpcr19 경로의 활성화에 의한 골수 유래 면역 조절 세포 및 면역 조절 b 림프구의 체내외 증폭

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993003137A1 (en) * 1991-08-07 1993-02-18 Washington University Human substance p receptor
DK0647275T3 (da) * 1992-06-23 2005-01-24 Sinai School Medicine Kloning og ekspression af receptoren for gonatotropin-frigörende hormon
WO1994009116A1 (en) * 1992-10-15 1994-04-28 Merck & Co., Inc. Cho cells expressing human endothelin receptors
GB2283239A (en) * 1993-10-29 1995-05-03 Ucb Sa Human H1 histamine receptor
US5677184A (en) * 1994-04-19 1997-10-14 Takeda Chemical Industries, Ltd. CHO cells that express human LH-RH receptor

Also Published As

Publication number Publication date
AU6043796A (en) 1996-12-30
CA2220715C (en) 2004-11-02
AU730875B2 (en) 2001-03-15
EP0830600A1 (de) 1998-03-25
DK0830600T3 (da) 2003-12-22
DE69629684D1 (de) 2003-10-02
AU730875C (en) 2003-01-16
WO1996041169A1 (en) 1996-12-19
EP0830600A4 (de) 2000-04-05
EP0830600B1 (de) 2003-08-27
CA2220715A1 (en) 1996-12-19
JPH11507518A (ja) 1999-07-06
DE69629684T2 (de) 2004-02-26

Similar Documents

Publication Publication Date Title
DE69629684D1 (de) Funktioneller bioassay für an g-protein gekoppelte rezeptoragonisten und antagonisten
Tsuboi et al. Prostanoid receptor subtypes
Moore et al. Cell-based versus isolated target screening: how lucky do you feel?
Delapp et al. Determination of [35S] guanosine-5′-O-(3-thio) triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay
Gao et al. Allosteric modulation and functional selectivity of G protein-coupled receptors
Sugden et al. Melatonin receptor pharmacology: toward subtype specificity
Neher et al. Intracellular calcium release mediated by two muscarinic receptor subtypes
Lin et al. Rapid measurements of intracellular calcium using a fluorescence plate reader
Doijen et al. Advantages and shortcomings of cell-based electrical impedance measurements as a GPCR drug discovery tool
Price et al. FlexStation examination of 5-HT3 receptor function using Ca2+-and membrane potential-sensitive dyes: advantages and potential problems
DE69835301D1 (de) Verfahren zur identifizierug oder testung von agonisten für bzw. antagonisten gegen ppar
WO2000049416A3 (en) Receptor assay for detecting an effect test compounds have on a particular membrane receptor
CA2279881A1 (en) A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease
EP1012241A4 (de) Testverfahren für agonisten und antagonisten des g protein gekoppelten rezeptors
Benians et al. The dynamics of formation and action of the ternary complex revealed in living cells using a G-protein-gated K+ channel as a biosensor
EP1266037B1 (de) High throughput screening durch messen der intrazellulären kalziumspiegel
US6645733B1 (en) Fluorescent intensity method for assaying binding between proteins or peptides
Leitner et al. The relationship between somatostatin binding and cyclic AMP-stimulated protein kinase inhibition
Allen et al. A homogeneous high throughput nonradioactive method for measurement of functional activity of Gs-coupled receptors in membranes
Lundin et al. Development of a time-resolved fluorescence resonance energy transfer assay (cell TR-FRET) for protein detection on intact cells
Reinscheid et al. High-throughput real-time monitoring of Gs-coupled receptor activation in intact cells using cyclic nucleotide-gated channels
Zhang et al. Action of alpha 2A-adrenergic receptors in circular smooth muscle of canine proximal colon
WO1999055901A3 (en) Screening assay for identifying human purinoreceptor ligands
Crouch et al. New strategies in drug discovery for GPCRs: high throughput detection of cellular ERK phosphorylation
Varney et al. Discovery of subtype-selective metabotropic glutamate receptor ligands using functional HTS assays

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties